Solara Active

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE624Z01016
  • NSEID: SOLARA
  • BSEID: 541540
INR
638.45
-16.7 (-2.55%)
BSENSE

Oct 09

BSE+NSE Vol: 2.12 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003017,
    "name": "Solara Active",
    "stock_name": "Solara Active",
    "full_name": "Solara Active Pharma Sciences Ltd",
    "name_url": "stocks-analysis/solara-active",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "638.45",
    "chg": -16.7,
    "chgp": "-2.55%",
    "dir": -1,
    "prev_price": "655.15",
    "mcapval": "3,161.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 541540,
    "symbol": "SOLARA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE624Z01016",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "2.12 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/solara-active-1003017-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Solara Active Pharma Sciences consolidated net profit rises 55.04% in the June 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-23 14:16:17",
        "description": "Solara Active Pharma Sciences consolidated net profit rises 55.04% in the June 2026 quarter  Business Standard..."
      }
    ],
    "total": 2,
    "sid": "1003017",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/solara-active-pharma-sciences-1003017"
  },
  "announcements": [
    {
      "caption": "Intimation To Furnish Valid PAN KYC Details And Nomination By Shareholders Holding Physical Shares",
      "datetime": "26-Sep-2026",
      "details": "Intimation to furnish valid PAN. KYC details and Nomination by shareholders holding physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Sep-2026",
      "details": "Intimation regarding Closure of Trading window for the quarter ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "22-Sep-2026",
      "details": "Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizers report of the Ninth Annual General Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has declared <strong>30%</strong> dividend, ex-date: 18 Aug 21",
          "dt": "2021-08-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has announced <strong>1:3</strong> rights issue, ex-date: 15 May 24",
          "dt": "2024-05-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock-recommendationAnnouncement

Intimation To Furnish Valid PAN KYC Details And Nomination By Shareholders Holding Physical Shares

26-Sep-2026 | Source : BSE

Intimation to furnish valid PAN. KYC details and Nomination by shareholders holding physical Shares

Closure of Trading Window

25-Sep-2026 | Source : BSE

Intimation regarding Closure of Trading window for the quarter ended September 30 2026

Shareholder Meeting / Postal Ballot-Scrutinizers Report

22-Sep-2026 | Source : BSE

Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizers report of the Ninth Annual General Meeting

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Solara Active Pharma Sciences Ltd has declared 30% dividend, ex-date: 18 Aug 21

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Solara Active Pharma Sciences Ltd has announced 1:3 rights issue, ex-date: 15 May 24